Tofacitinib Tablets Manufacturer & Global Exporter | 5mg & 11mg
Lifechem Healthcare Private Limited is a leading tofacitinib tablets manufacturer and exporter based in Surat, India, dedicated to delivering high-quality autoimmune therapies globally. We specialize in the production and reliable bulk supply of Tofacitinib Tablets (5mg & 11mg), a type of Janus kinase (JAK) inhibitor, which helps patients manage the symptoms associated with rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
Formulated in our state-of-the-art WHO-GMP certified facilities, our Tofacitinib products meet stringent international regulatory standards for efficacy, safety, and bioavailability.
Lifechem as Your Partner and Tofacitinib Tablets Manufacturer
-
WHO-GMP Certified: Manufactured in facilities that strictly adhere to Global Good Manufacturing Practices.
-
Comprehensive Regulatory Support: We provide complete documentation, including COA, MOA, and Stability Data, to ensure smooth registration and customs clearance in your target country.
-
Global Export Reach: Currently exporting pharmaceutical products to over 40 countries with a robust logistics network ensuring timely, secure delivery.
-
Flexible Packaging Solutions: Available in standard blister packs or customized bulk packaging tailored for distinct export markets.
Tofacitinib 5mg & 11mg Tablets Specifications
Available Strengths:
-
5 mg (Immediate Release)
-
11 mg (Extended Release)
Tofacitinib is a potent, oral Janus kinase (JAK) inhibitor. It functions by inhibiting the JAK-STAT signaling pathway, which plays a pivotal role in the immune response and inflammation processes. By interfering with these pathways, Tofacitinib effectively modulates the immune system to reduce inflammation and associated symptoms in autoimmune conditions.
This product is formulated using USP / BP / IP grade Active Pharmaceutical Ingredients (API) and manufactured under strict quality control standards to ensure maximum efficacy and stability.
Clinical Indications
Tofacitinib is clinically indicated for the management of the following conditions:
-
Rheumatoid Arthritis (RA): For the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate.
-
Psoriatic Arthritis (PsA): For the treatment of adult patients with active PsA who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
-
Ulcerative Colitis (UC): For the treatment of adult patients with moderately to severely active UC.
-
Juvenile Idiopathic Arthritis (JIA): For the treatment of active polyarticular course JIA (depending on local regulatory approval).
Export Packaging & Storage Guidelines
Configuration & Packaging: We offer adaptable packaging solutions tailored to your specific market requirements and local regulatory needs:
-
Standard Blister Packs: 6 x 10 Tablets
-
Standard Blister Packs: 10 x 10 Tablets
-
Custom Bulk Packaging available upon buyer request.
Storage Instructions: To maintain optimal product stability and integrity throughout the global supply chain:
-
Store at controlled room temperature, typically below 25°C (77°F).
-
Excursions permitted between 15°C and 30°C (59°F and 86°F).
-
Keep in the original package to protect from moisture and light.
Global Trade & Bulk Inquiries for Tofacitinib Sourcing
To request a quote, COA, or discuss export contract manufacturing for Tofacitinib, reach out to our global sales team today.
B2B Trade Disclaimer: The information provided above is for general informational and B2B trade purposes only. It is not intended as medical advice. Tofacitinib is a prescription-only medicine and should be used strictly under the guidance of a qualified healthcare professional.